A Trial Investigating the Pharmacodynamic Properties of NN5401 in Subjects With Type 1 Diabetes
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of this trial is to investigate the
pharmacodynamic response (the effect of the investigated drug on the body) of insulin
degludec/insulin aspart (IDegAsp) at steady state in subjects with type 1 diabetes.